China Smart Health (00348) announced interim results. Shareholders' losses of HK$29.094 million were converted from profit to loss year-on-year

According to the Zhitong Finance App, China Smart Health (00348) announced interim results for the six months ended June 30, 2026. The group obtained revenue of HK$36.462 million, a year-on-year decrease of 28.59%; the company's owners should have lost HK$29.94 million during the same period last year, with a profit of HK$1,418,000; loss per share of HK$3.78 cents.

According to the announcement, the decrease in revenue was due to (1) the increase in realized losses from about HK$200,000 to about HK$11.7 million during the corresponding period from about HK$200,000 to around HK$11.7 million during the corresponding period; and (2) a decrease in revenue from the Chinese Medicine Health Products Division from approximately HK$51 million during the corresponding period to approximately HK$47.9 million during the period.